https://pharmadog.xyz/news/636695 pharmadog en 2026-11-04T13:57:21.000Z Boehringer Ingelheim partners with Sino Biopharma on $7 billion cancer drug deal https://pharmadog.xyz/news/636739 pharmadog en 2026-11-04T13:38:17.000Z Democrats Wyden and Sanders poised to lead Finance and Health committees after Senate flip https://pharmadog.xyz/news/636719 pharmadog en 2026-11-04T13:33:26.000Z Novo and Pfizer say MFN pricing agreements remain unchanged despite Democratic gains in Congress https://pharmadog.xyz/news/636740 pharmadog en 2026-11-04T13:01:33.000Z Biotech startups opt out of AI for drug discovery, say STAT https://pharmadog.xyz/news/123087 pharmadog en 2026-11-04T12:59:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/636741 pharmadog en 2026-11-04T12:30:43.000Z Former Madrigal exec sues, alleging retaliation after flagging safety concerns on approved MASH drug https://pharmadog.xyz/news/636571 pharmadog en 2026-11-04T12:25:20.000Z Novo claims 80% share of oral GLP-1 market as rivalry with Lilly intensifies https://pharmadog.xyz/news/636742 pharmadog en 2026-11-04T12:15:08.000Z Democrats win Congress and doctors secure key seats, shifting health policy direction https://pharmadog.xyz/news/636572 pharmadog en 2026-11-04T12:12:00.000Z Pfizer targets Europe first for upcoming Lyme disease vaccine amid rising US cases https://pharmadog.xyz/news/636547 pharmadog en 2026-11-04T12:03:29.000Z Novo says launch of obesity drug CagriSema in Europe delayed by a couple of years https://pharmadog.xyz/news/636379 pharmadog en 2026-11-04T11:47:26.000Z AbbVie licenses Nxera's EP4 gut-targeting IBD program for up to $1.47 billion https://pharmadog.xyz/news/636403 pharmadog en 2026-11-04T11:17:12.000Z Big pharma Q3 earnings roll out as FDA launches rare-disease initiative and uniQure's Huntington's gene therapy enters review https://pharmadog.xyz/news/636211 pharmadog en 2026-11-04T10:30:55.000Z Novo projects flat 2026 sales as CFO exits, marking an upgrade from prior expectations https://pharmadog.xyz/news/635979 pharmadog en 2026-11-04T09:30:00.000Z American expatriate in Malta finds free health care but misses digital patient portal https://pharmadog.xyz/news/636522 pharmadog en 2026-11-04T07:21:00.000Z AbbVie pays $100M upfront in $1.4B deal for Nxera's phase-1 IBD candidate https://pharmadog.xyz/news/635599 pharmadog en 2026-11-04T07:04:40.000Z Minghui Pharma sells Japanese rights to its Phase 3 thyroid eye disease drug for $110 million upfront https://pharmadog.xyz/news/635287 pharmadog en 2026-11-04T05:54:00.000Z Flagship partner Louisa Helms credits high-school librarian for sparking biotech career https://pharmadog.xyz/news/636354 pharmadog en 2026-11-04T05:19:00.000Z Ultragenyx to cut 20% of staff and halve R&D budget as it pivots to commercial sales https://pharmadog.xyz/news/636186 pharmadog en 2026-11-04T05:04:00.000Z Sanofi halts Nurix STAT6 degrader program two months after phase-1 start https://pharmadog.xyz/news/635288 pharmadog en 2026-11-04T05:02:00.000Z China targets five $1 billion blockbuster drugs by 2030, two already achieved https://pharmadog.xyz/news/635139 pharmadog en 2026-11-04T04:38:26.000Z Democrats Gain Senate Control, Poised to Reverse Trump Health Care Policies https://pharmadog.xyz/news/635910 pharmadog en 2026-11-04T04:04:00.000Z Novo reports $2.2 bn impairment hit as pipeline setbacks spur deal hunt https://pharmadog.xyz/news/633723 pharmadog en 2026-11-03T21:55:33.000Z Ultragenyx cuts 20% of workforce and abandons Wilson disease gene therapy after mixed Q3 results https://pharmadog.xyz/news/633599 pharmadog en 2026-11-03T20:53:20.000Z Servier’s $1.55 billion Becker muscular dystrophy drug fails pivotal Phase 3 trial https://pharmadog.xyz/news/633600 pharmadog en 2026-11-03T20:33:22.000Z MGB CEO's vague email on financial challenges fuels anxiety after recent layoffs https://pharmadog.xyz/news/633387 pharmadog en 2026-11-03T19:27:54.000Z Servier’s $1.5 billion muscular dystrophy drug sevasemten fails pivotal trial https://pharmadog.xyz/news/633388 pharmadog en 2026-11-03T19:18:32.000Z Pfizer CEO says Democratic gains unlikely to alter Trump-era MFN pricing agreements https://pharmadog.xyz/news/633411 pharmadog en 2026-11-03T19:01:53.000Z Pfizer partners with Sciwind to launch GLP-1 obesity drug Ecnoglutide in China https://pharmadog.xyz/news/633219 pharmadog en 2026-11-03T18:44:00.000Z Live discussion to assess how US midterm elections could reshape biopharma policy https://pharmadog.xyz/news/633115 pharmadog en 2026-11-03T17:32:00.000Z Vertex, ahead of FDA decision, calms fears surrounding kidney drug https://pharmadog.xyz/news/632799 pharmadog en 2026-11-03T16:25:38.000Z Compass Pathways to file FDA approval for psilocybin depression therapy within weeks https://pharmadog.xyz/news/632607 pharmadog en 2026-11-03T15:37:30.000Z Endpoints Announces Second Annual Health Tech Day with Virtual Sessions https://pharmadog.xyz/news/632651 pharmadog en 2026-11-03T15:36:21.000Z Compass Pathways leads race for first psychedelic drug approval, non-profit rivals https://pharmadog.xyz/news/632652 pharmadog en 2026-11-03T15:29:07.000Z Midterm elections could reshape health policy, Medicare Advantage and insurance, STAT analysis says https://pharmadog.xyz/news/632631 pharmadog en 2026-11-03T15:15:02.000Z Lonza to acquire five Merck KGaA US facilities, more than doubling its US footprint https://pharmadog.xyz/news/632608 pharmadog en 2026-11-03T15:04:17.000Z Pfizer raises 2026 outlook as oncology and migraine growth balances Covid product decline https://pharmadog.xyz/news/632439 pharmadog en 2026-11-03T14:56:47.000Z Novartis ends discovery-stage collaboration with BioArctic amid broader biotech updates https://pharmadog.xyz/news/632483 pharmadog en 2026-11-03T14:51:12.000Z FDA and CMS seek state partnerships to shape health AI regulations and liability protections https://pharmadog.xyz/news/632484 pharmadog en 2026-11-03T14:44:54.000Z FDA grants tentative approval for Dr. Reddy’s generic HIV prevention shot, expanding access in low- and middle-income countries https://pharmadog.xyz/news/632463 pharmadog en 2026-11-03T14:29:01.000Z Neurocrine launches new safety study after another death linked to Prader-Willi drug Vykat https://pharmadog.xyz/news/632464 pharmadog en 2026-11-03T14:08:49.000Z Novartis ends $772M BioArctic brain-delivery partnership https://pharmadog.xyz/news/632295 pharmadog en 2026-11-03T13:53:39.000Z Pfizer reports flat Q3 revenue as non-COVID sales rise 7% and acquired products grow 32% https://pharmadog.xyz/news/632315 pharmadog en 2026-11-03T13:48:16.000Z New York records first measles death in three decades as vaccination rates slip https://pharmadog.xyz/news/632335 pharmadog en 2026-11-03T13:46:00.000Z Medicare Part D premiums expected to rise 50% on average in 2027, KFF warns seniors to compare plans https://pharmadog.xyz/news/632504 pharmadog en 2026-11-03T13:41:00.000Z UniQure slated for FDA decision by May 1 as analysts see potential for first Huntington’s disease therapy https://pharmadog.xyz/news/632147 pharmadog en 2026-11-03T12:52:30.000Z First U.S. bird flu death of 2026 reported in Washington state after cattle exposure https://pharmadog.xyz/news/632103 pharmadog en 2026-11-03T12:01:37.000Z Bayer CEO says company is negotiating a most-favored-nation trade pact with US administration https://pharmadog.xyz/news/631599 pharmadog en 2026-11-03T09:54:12.000Z Merck KGaA sells its CDMO business and US sites to Lonza https://pharmadog.xyz/news/632583 pharmadog en 2026-11-03T09:35:00.000Z Rhythm Pharmaceuticals expands LG Chem obesity drug license, total payout up to $855 million https://pharmadog.xyz/news/631643 pharmadog en 2026-11-03T09:30:00.000Z Mortality rates remain higher in states that supported Trump, highlighting political health divide in 2024 https://pharmadog.xyz/news/631644 pharmadog en 2026-11-03T09:30:00.000Z Physician finds meditation boosts resilience and patient care after intense trauma cases https://pharmadog.xyz/news/631645 pharmadog en 2026-11-03T09:30:00.000Z Scientists question safety and benefits of three-parent IVF as new UK data raise concerns https://pharmadog.xyz/news/632414 pharmadog en 2026-11-03T08:41:00.000Z AbbVie halts development of livmoniplimab after deeming benefit limited https://pharmadog.xyz/news/632415 pharmadog en 2026-11-03T08:29:00.000Z Pfizer drops phase 2 pulmonary arterial hypertension candidate amid pipeline cut https://pharmadog.xyz/news/635574 pharmadog en 2026-11-03T05:49:00.000Z AbbVie commits £120 million to new Oxford R&D hub, boosting UK life‑science footprint https://pharmadog.xyz/news/632582 pharmadog en 2026-11-03T05:05:00.000Z Philips earmarks $322 million for pending DOJ settlement on sleep-apnea device recall https://pharmadog.xyz/news/633490 pharmadog en 2026-11-03T05:00:00.000Z Compact Medical issues recall and updated instructions for ButterflyBVM bag-valve-mask resuscitators due to bellows holes https://pharmadog.xyz/news/631742 pharmadog en 2026-11-03T04:55:00.000Z Novartis ends $800M neuroscience partnership with BioArctic after 14 months https://pharmadog.xyz/news/632754 pharmadog en 2026-11-03T04:09:00.000Z Abbott reports 30‑day success in Tectonic trial of SonicForce coronary IVL system https://pharmadog.xyz/news/634073 pharmadog en 2026-11-03T00:00:00.000Z FDA reports rise in unannounced drug inspections in China and India for FY 2026 https://pharmadog.xyz/news/634074 pharmadog en 2026-11-03T00:00:00.000Z Stakeholders submit over 500 comments urging FDA to shape regulation of generative AI medical devices https://pharmadog.xyz/news/634075 pharmadog en 2026-11-03T00:00:00.000Z Legal experts advise European healthcare manufacturers on navigating complex environmental regulations https://pharmadog.xyz/news/629391 pharmadog en 2026-11-02T21:03:38.000Z Karyopharm files for Chapter 11 bankruptcy as it pursues merger with Ayrmid https://pharmadog.xyz/news/629243 pharmadog en 2026-11-02T20:44:40.000Z Washington resident dies after bird flu infection linked to dairy cattle exposure https://pharmadog.xyz/news/629031 pharmadog en 2026-11-02T19:43:03.000Z AbbVie signs up to $757M deal with Beijing's Brise Pharma for two preclinical migraine candidates https://pharmadog.xyz/news/628755 pharmadog en 2026-11-02T18:44:22.000Z WuXi Biologics and Fresenius strike major deal for up to 37 biosimilars over the next decade https://pharmadog.xyz/news/633174 pharmadog en 2026-11-02T17:19:00.000Z Brad's Raw Chips recalls kale chips over potential thallium contamination https://pharmadog.xyz/news/628611 pharmadog en 2026-11-02T17:15:16.000Z FDA policy allowing compounding of unapproved peptides raises safety and development concerns https://pharmadog.xyz/news/628651 pharmadog en 2026-11-02T17:07:00.000Z Karyopharm files for Chapter 11 and plans auction with Gamida Cell parent Ayrmid as lead bidder https://pharmadog.xyz/news/628631 pharmadog en 2026-11-02T17:05:28.000Z Midterm voters weigh health-care costs as urgent-care visits billed like ERs https://pharmadog.xyz/news/628443 pharmadog en 2026-11-02T16:52:45.000Z Sun Pharma halts eye-care drug production in India after regulator cited quality failures https://pharmadog.xyz/news/628463 pharmadog en 2026-11-02T16:47:33.000Z Study finds psilocybin does not produce lasting anxiety or depression relief in mice https://pharmadog.xyz/news/628464 pharmadog en 2026-11-02T16:13:46.000Z FDA grants tentative approval for generic HIV prevention shot, boosting access in low-income nations https://pharmadog.xyz/news/628419 pharmadog en 2026-11-02T16:10:20.000Z FDA sets May 1 decision deadline for UniQure’s Huntington’s disease gene therapy after advisory committee meeting https://pharmadog.xyz/news/628251 pharmadog en 2026-11-02T15:28:10.000Z Karyopharm Therapeutics to merge with Ayrmid as it enters bankruptcy https://pharmadog.xyz/news/629342 pharmadog en 2026-11-02T15:28:00.000Z FDA places uniQure’s Huntington’s gene therapy in priority review, targeting May 2027 approval https://pharmadog.xyz/news/628275 pharmadog en 2026-11-02T15:16:02.000Z Tiziana's lower-dose foralumab cuts neuroinflammation in SPMS, but higher dose fails https://pharmadog.xyz/news/628252 pharmadog en 2026-11-02T15:11:58.000Z FDA places Bright Minds seizure drug BMB-101 on partial hold over mouse toxicity, shares plunge